AL
ARNA

Airain Ltd’s Arena Pharmaceuticals Inc ARNA Stock Holding History

Airain Ltd’s Portfolio ARNA Stock Details ARNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q2 		$178K Buy
+10,535
New +$144K 0.01% 763
2014
Q1 		– Sell
-23,047
Closed -$1.35M – 904
2013
Q4 		$1.35M Buy
+23,047
New +$1.2M 0.17% 154

Other funds holding ARNA

Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
GPP
Great Point Partners Greenwich, Connecticut $435M AUM 318.81% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Balyasny Asset Management
Balyasny Asset Management Chicago, Illinois $77.1B AUM 42.89% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
CCM
Camber Capital Management Boston, Massachusetts $1.07B AUM 8.19% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return

Airain Ltd's ARNA Position: Q2 2017 in Review

Airain Ltd opened a new position in Arena Pharmaceuticals Inc (ARNA) in Q2 2017: 10,535 shares worth $178K. The stake represents 0.01% of the portfolio and ranks #763 among its holdings. This is a return to the name: Airain Ltd previously reported a position in ARNA as recently as Q4 2013.

Airain Ltd first reported a position in ARNA in Q4 2013 and has held it in 2 quarters since. The position peaked at $1.35M in Q4 2013. 102 funds tracked by Wall St. Rank hold ARNA as of Q2 2017.

  • Airain Ltd held 10,535 shares of Arena Pharmaceuticals Inc worth $178K as of Q2 2017.
  • Arena Pharmaceuticals Inc was a new Airain Ltd position in Q2 2017.
  • Arena Pharmaceuticals Inc made up 0.01% of Airain Ltd's portfolio in Q2 2017, its #763 holding.
  • Airain Ltd first reported a position in Arena Pharmaceuticals Inc in Q4 2013 and has held it in 2 quarters since.
  • Airain Ltd's Arena Pharmaceuticals Inc position peaked at $1.35M in Q4 2013.
  • 102 funds tracked by Wall St. Rank held Arena Pharmaceuticals Inc as of Q2 2017.

Based on Airain Ltd's 13F filing for Q2 2017, filed 8 Aug 2017.